The World Prescription Drug Market Report
The back-lash of the 2007/2008 global financial crisis led to pressure from governments reducing healthcare budgets. This, in turn, left the global prescription market feeling the pinch. But with the global population ageing, the rise of chronic illnesses and universal healthcare schemes being unveiled worldwide, the prescription drug market has the opportunity for growth – but in what countries?
Key Market Questions Answered by The World Prescription Drug Market Report:
- Which country has the highest prescription drug expenditure?
- Which Middle East country is forecast to have the strongest growth?
- What is the number of dispensed prescriptions in the US, by therapy area?
- How does the Brazilian market compare with China, Russia and India, historically?
- What are the key trends affecting the Latin American countries?
The World Prescription Drugs Market Report 2013 is the perfect accomplice for any industry executive in today’s challenging global market environment. The need for hard facts and statistics to back up everyday business decisions is essential and it is this report that can provide you with that key information.
With hundreds of comparable data points available, who else will provide you with:
- Our exclusive analysts industry opinion – not found anywhere else!
- Key historical data and industry forecasts for 72 countries worldwide
- In-depth prescription drug sale indicators for 2009 – 2017
- Detailed tables and representative graphs with key comparisons such as the top 30 markets by value and by per-capita spending
Table Of Contents
BMI Industry View 9
Industry Forecast 15
Africa 15
Algeria 16
Table: Algeria Prescription Drug Market Indicator. Historical Data and Forecasts 17
Egypt18
Table: Egypt Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 19
Ghana 20
Table: Prescription Drug Sales. 2009-2017 21
Kenya 22
Table: Kenya Prescription Drug Market Indicators, Historical Data and Forecasts 23
Morocco 24
Table: Leading Therapeutic Classes. 2010 25
Table: Private Pharmacy Sales Value and Volume Bi Principal Therapeutic Categories. 2010 26
Table: Morocco Prescription Drug Market Indicators, Historical Data and Forecasts 26
Nigeria 27
Table: Nigeria Prescription Drug Market Indicators, Historical Data and Forecasts 29
South Africa
Table: South Africa Prescription Drug Market Indicators, Historical Data, and Forecasts 31
Industry Forecast 32
Asia Pacific 32
Australia 33
Table: Pharmaceutical Sales. 2009-2017 34
Bangladesh 35
Table: Bangladesh Prescription Drug Market Indicators, Historical Data And Forecasts 36
China 37
Table: Prescription Drug Sales Indicators. 2009-2017 38
Hong Kong 39
Table: Prescription Drug Sales Indicators. 2009-20! 7 40
India 41
Table: Prescription Drug Sales. 2009-2017 42
Indonesia 43
Table: Indonesia Prescription Drug Market Indicators, Historical Data and Forecasts 44
Japan 45
Table: Prescription Drug Market Indicators, Historical Data And Forecasts 46
Malaysia 47
Table: Prescription Drug Sales Indicators 2009-2017 48
New Zealand 49
Table: New Zealand Prescription Drug Market Indicators, Historical Data and Forecasts 50
Pakistan 51
Table: Pakistan Prescription Drug Market Indicators, Historical Data and Forecasts 53
Philippines 54
Table: Philippines Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017
Singapore 56
Table: Pharmaceutical Sales Indicators 2009-2017 57
South Korea 58
Table: South Korea Prescription Drug Market Indicators, Historical Data and Forecasts 59
Taiwan 60
Table: Taiwan Prescription Drug Market Indicators, Historical Data and Forecasts 61
Thailand 62
Table: Thailand Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 63
Vietnam 64
Table: Prescription Drug Sales Indicators. 2009-2017 66
Industry Forecast 67
Europe 67
Belarus 68
Table: Belarus Prescription Drug Market Indicators, Historical Data and Forecasts 69
Belgium 70
Table: Belgium Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 71
Bulgaria 72
Table: Bulgaria Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 74
Table: Leading ATC Groups by Volume, 2009 74
Table: Leading ATC Groups by Value, 2009 75
Croatia 76
Table: Croatia Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2018 78
Czech Republic 79
Table: Czech Prescription Drug Market Indicators, Historical Data and Forecast 81
Estonia 82
Table: Leading ATC Groups by Pharmaceutical Sales, 2004-2010 (%) 84
Table: Estonia Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 86
France 87
Table: France Prescription Drug Market Indicators, Historical Data and Forecasts 88
Germany 89
Table: Retail Pharmaceutical Expenditure. 2003-10 (EURbn) 90
Table: Retail Pharmaceutical Expenditure. 2003-10 (Packages, ms) 90
Table: Retail Pharmaceutical Expenditure. 2003-10 (Average Price per Pack, EUR) 91
Table: Germany Prescription Drug Market Indicators, Historical Data and Forecasts 92
Greece 93
Table: Prescription Drug Sales Indicators. 2009-2017 94
Hungary 95
Table: Hungary Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 96
Italy 97
Table: Prescription Drug Market Indicators, Historical Data and Forecasts 99
Kazakhstan 100
Table: Kazakhstan Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 101
Latvia 102
Table: Latvia Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 103
Lithuania 104
Table: Lithuania Prescription Drug Market Indicators, Historical Data and Forecasts, 2019-2017 106
Moldova 107
Table: Moldova Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 108
Netherlands 109
Poland 111
Table: Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 112
Portugal 113
Table: Prescription Drug Market Indicators, Historical Data and Forecasts 115
Romania 116
Table: Romania Prescription Drug Market Indicators, Historical Data And Forecasts. 2009-201 7 117
Russia 118
Table: Russia Prescription Drug Marker Indicators, Historical Data and Forecasts 119
Serbia 120
Table: Serbia Prescription Drug Market Indicators, Historical Data and Forecasts 121
Slovakia 122
Table: Prescription Drug Market Indicators, Historical Data and Forecasts 124
Slovenia 125
Table: Slovenia Prescription Drug Market Indicators, Historical Data and Forecasts 126
Spain 127
Table: Spain Prescription Drug Market Indicators, Historical Data and Forecasts 128
Sweden 129
Table: Table: Pharmaceutical Sales By Leading Product At Wholesale Prices. 2007-2010 (SEKmn) 129
Table: Table: Pharmaceutical Sales By Therapeutic Group At Wholesale Prices. 200 7-2010 (SEKmn) 131
Table: Table: Inpatient Hospital Sales By Leading Pharmaceutical Group At Retail Prices. 2007-2010 (SEKmn) 132
Table: Table: Swede,, Prescription Drug Market Indicators, Historical Data And Forecasts 133
Switzerland 134
Table: Switzerland Patented Drug Market Indicators, Historical Data and Forecasts 135
Turkey 136
Table: Turkey Prescription Drug 1.larket Indicators, Historical Data and Forecasts 137
United Kingdom 138
Table: Prescriptions & Cost hr Therapeutic Area in the UK. 2011 139
Table: UK Prescription Drug Market Indicators, Historical Data and Forecasts 143
Ukraine 144
Table: Ukraine - Prescription Drug Market Indicators, Historical Data and Forecasts 145
Uzbekistan 146
Table: Uzbekistan Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 147
Industry Forecast 148
Latin America 148
Argentina 149
Table: Argentina Prescription Drug Market Indicators, Historical Data arid Forecasts 150
Brazil 151
Table: Brazil Prescription Drug Market Indicators, Historical Data And Forecasts 152
Chile 153
Table: Chile Prescription Drug Market Indicators, Historical Data & Forecasts 154
Colombia 155
Table: Colombia Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 156
Mexico 157
Table: Prescription Drug Saks Indicators. 2009-2017 158
Peru 159
Table: Peru Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-201 7 160
Venezuela 161
Table: Prescription Drug Sales. 2009-2017 162
Industry Forecast 163
Middle East 163
Bahrain 164
Table: Bahrain Prescription Drug Market Indicators, Historical Data and Forecasts 165
Iran 166
Israel 168
Table: Israel Prescription Drug Market Indicators, Historical Data and Forecasts 169
Jordan 170
Table: Jordan Prescription Drug Market Indicators, Historical Data and Forecasts 2009-2017 171
Kuwait 172
Table: Prescription Drug Sales Indicators 2009-2017 173
Lebanon 174
Table: Lebanon Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 175
Oman 176
Table: Oman Prescription Drug Market Indicators, Historical Data and Forecasts 2009-2017 177
Qatar 178
Table: Qatar Prescription Drug Market Indicators, Historical Data, and Forecasts 179
Saudi Arabia 180
Table: Saudi Arabia Prescription Drug Market Indicators, Historical Data and Forecasts 181
UAE 182
Table: UAE Healthcare Demand Split by Therapeutic Area 182
Table: Prescription Drug Sales Indicators 20(19-2017 185
Industry Forecast 186
North America 186
Canada 187
Table: Prescription Drug Market Indicators, Historical Data and Forecasts 188
US 189
Table: US Prescription Drug Market Indicators, Historical Data and Forecasts 191
Table: Number Of Dispensed Prescriptions by Therapy Area in the US (mn) 191
Table: Number Of Dispensed Prescriptions by Active Ingredient in the US (mn) 191
Glossary 193
Methodology 195
Pharmaceutical Expenditure Forecast Model 195
Healthcare Expenditure Forecast Model 195
Notes on Methodology 196